KLHL34
gene geneOn this page
Also known as FLJ34960RP11-450P7.3
Summary
KLHL34 (kelch like family member 34, HGNC:26634) is a protein-coding gene on chromosome Xp22.12, encoding Kelch-like protein 34 (Q8N239).
Located in extracellular space.
Source: NCBI Gene 257240 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 79 total — 1 pathogenic
- MANE Select transcript:
NM_153270
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26634 |
| Approved symbol | KLHL34 |
| Name | kelch like family member 34 |
| Location | Xp22.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ34960, RP11-450P7.3 |
| Ensembl gene | ENSG00000185915 |
| Ensembl biotype | protein_coding |
| Entrez | 257240 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000379499
RefSeq mRNA: 1 — MANE Select: NM_153270
NM_153270
CCDS: CCDS14199
Canonical transcript exons
ENST00000379499 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001481325 | 21654690 | 21658330 |
Expression profiles
Bgee: expression breadth broad, 98 present calls, max score 95.56.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0732 / max 27.1738, expressed in 21 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 198696 | 0.0330 | 12 |
| 198694 | 0.0278 | 10 |
| 198695 | 0.0124 | 6 |
Top tissues by expression
223 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 95.56 | gold quality |
| biceps brachii | UBERON:0001507 | 92.59 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 89.09 | gold quality |
| quadriceps femoris | UBERON:0001377 | 88.23 | gold quality |
| vastus lateralis | UBERON:0001379 | 87.93 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 87.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 86.55 | gold quality |
| cerebellar vermis | UBERON:0004720 | 85.62 | silver quality |
| buccal mucosa cell | CL:0002336 | 85.15 | gold quality |
| deltoid | UBERON:0001476 | 83.18 | gold quality |
| muscle tissue | UBERON:0002385 | 81.57 | gold quality |
| gastrocnemius | UBERON:0001388 | 80.38 | gold quality |
| muscle of leg | UBERON:0001383 | 80.30 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.01 | gold quality |
| body of tongue | UBERON:0011876 | 75.81 | gold quality |
| jejunum | UBERON:0002115 | 69.48 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 66.54 | silver quality |
| tongue | UBERON:0001723 | 66.44 | gold quality |
| jejunal mucosa | UBERON:0000399 | 65.10 | gold quality |
| heart left ventricle | UBERON:0002084 | 64.13 | gold quality |
| superior surface of tongue | UBERON:0007371 | 64.07 | gold quality |
| cardiac ventricle | UBERON:0002082 | 63.55 | gold quality |
| apex of heart | UBERON:0002098 | 61.76 | gold quality |
| duodenum | UBERON:0002114 | 61.17 | gold quality |
| prefrontal cortex | UBERON:0000451 | 60.12 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 59.83 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 59.19 | gold quality |
| myocardium | UBERON:0002349 | 58.18 | gold quality |
| heart | UBERON:0000948 | 57.07 | gold quality |
| endothelial cell | CL:0000115 | 56.21 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.62 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
31 targeting KLHL34, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-557 | 99.96 | 70.01 | 1640 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-12133 | 99.92 | 71.82 | 2006 |
| HSA-MIR-1271-5P | 99.91 | 71.99 | 1972 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-182-5P | 99.87 | 74.03 | 2589 |
| HSA-MIR-1208 | 99.70 | 68.28 | 1533 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-5584-5P | 99.49 | 68.22 | 2814 |
| HSA-MIR-4762-3P | 99.43 | 69.72 | 2363 |
| HSA-MIR-4312 | 99.34 | 67.30 | 511 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-892C-5P | 99.16 | 70.56 | 2116 |
| HSA-MIR-5100 | 99.11 | 67.52 | 1098 |
| HSA-MIR-3922-5P | 98.77 | 66.53 | 1059 |
| HSA-MIR-34B-3P | 98.70 | 67.40 | 1171 |
| HSA-MIR-6873-5P | 98.45 | 66.14 | 1417 |
| HSA-MIR-5691 | 98.23 | 67.02 | 1335 |
| HSA-MIR-6805-3P | 98.23 | 67.02 | 1334 |
| HSA-MIR-3614-3P | 97.81 | 67.15 | 582 |
| HSA-MIR-6787-3P | 97.75 | 66.17 | 1233 |
| HSA-MIR-500A-3P | 97.60 | 67.48 | 595 |
| HSA-MIR-6514-3P | 97.52 | 66.50 | 808 |
| HSA-MIR-1226-3P | 97.51 | 66.32 | 1063 |
| HSA-MIR-6736-3P | 96.98 | 65.22 | 1342 |
| HSA-MIR-3974 | 96.56 | 66.22 | 928 |
| HSA-MIR-8083 | 95.93 | 67.55 | 694 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Klhl34 | ENSMUSG00000047485 |
| rattus_norvegicus | Klhl34 | ENSRNOG00000024479 |
Paralogs (54): KLHL13 (ENSG00000003096), KLHL20 (ENSG00000076321), KEAP1 (ENSG00000079999), KLHL42 (ENSG00000087448), KLHL22 (ENSG00000099910), KLHL4 (ENSG00000102271), KLHL2 (ENSG00000109466), KLHL5 (ENSG00000109790), BACH2 (ENSG00000112182), KLHL18 (ENSG00000114648), KLHL24 (ENSG00000114796), IVNS1ABP (ENSG00000116679), KLHL12 (ENSG00000117153), KLHL29 (ENSG00000119771), KBTBD7 (ENSG00000120696), KLHL7 (ENSG00000122550), KLHL31 (ENSG00000124743), KLHDC7B (ENSG00000130487), KLHL36 (ENSG00000135686), KLHL8 (ENSG00000145332), KLHL3 (ENSG00000146021), KLHL35 (ENSG00000149243), KLHL1 (ENSG00000150361), BACH1 (ENSG00000156273), KLHL40 (ENSG00000157119), KLHL10 (ENSG00000161594), KLHL21 (ENSG00000162413), KLHDC8A (ENSG00000162873), KBTBD8 (ENSG00000163376), KBTBD6 (ENSG00000165572), KLHL26 (ENSG00000167487), KLHL30 (ENSG00000168427), KBTBD2 (ENSG00000170852), KLHL6 (ENSG00000172578), KLHL15 (ENSG00000174010), KLHL38 (ENSG00000175946), KBTBD11 (ENSG00000176595), KLHDC7A (ENSG00000179023), KLHL28 (ENSG00000179454), KBTBD3 (ENSG00000182359)
Protein
Protein identifiers
Kelch-like protein 34 — Q8N239 (reviewed: Q8N239)
All UniProt accessions (1): Q8N239
RefSeq proteins (1): NP_695002* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR006652 | Kelch_1 | Repeat |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR011705 | BACK | Domain |
| IPR015915 | Kelch-typ_b-propeller | Homologous_superfamily |
| IPR017096 | BTB-kelch_protein | Family |
Pfam: PF00651, PF07707, PF24681
UniProt features (11 total): repeat 6, domain 2, chain 1, compositionally biased region 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N239-F1 | 87.15 | 0.71 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 40 (showing top):
GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GATA1_01, YRTCANNRCGC_UNKNOWN, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_PROTEIN_CATABOLIC_PROCESS, GOCC_TRANSFERASE_COMPLEX, GOBP_PROTEOLYSIS, GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX, GOCC_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX, ER_Q6_02, GOCC_UBIQUITIN_LIGASE_COMPLEX, chrXp22, RAO_BOUND_BY_SALL4, MIR182_5P, MIR96_5P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): obsolete extracellular space (GO:0005615)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
548 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| KLHL34 | LSMEM2 | Q8N112 | 488 |
| KLHL34 | BAIAP3 | O94812 | 482 |
| KLHL34 | KCNN1 | Q92952 | 467 |
| KLHL34 | DAB2IP | Q5VWQ8 | 432 |
| KLHL34 | FABP3 | P05413 | 430 |
| KLHL34 | SHANK1 | Q9Y566 | 365 |
| KLHL34 | ABTB3 | A6QL63 | 364 |
| KLHL34 | DZIP1 | Q86YF9 | 350 |
| KLHL34 | RBM44 | Q6ZP01 | 350 |
| KLHL34 | KCTD2 | Q14681 | 345 |
| KLHL34 | KCTD4 | Q8WVF5 | 340 |
| KLHL34 | HELB | Q8NG08 | 335 |
| KLHL34 | BTBD6 | Q96KE9 | 328 |
| KLHL34 | TINAG | Q9UJW2 | 327 |
| KLHL34 | ARHGAP6 | O43182 | 321 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KLHL34 | BAG3 | psi-mi:“MI:0914”(association) | 0.530 |
| KLHL34 | HSP90AB1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NUDCD3 | KLHL34 | psi-mi:“MI:0915”(physical association) | 0.400 |
| NUDC | KLHL34 | psi-mi:“MI:0915”(physical association) | 0.400 |
| KLHL34 | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (68): HSPA8 (Affinity Capture-MS), STUB1 (Affinity Capture-MS), BAG1 (Affinity Capture-MS), HSPA2 (Affinity Capture-MS), BAG3 (Affinity Capture-MS), HSPA1B (Affinity Capture-MS), STIP1 (Affinity Capture-MS), HSPA6 (Affinity Capture-MS), CCT2 (Affinity Capture-MS), STUB1 (Affinity Capture-MS), HSPA1B (Affinity Capture-MS), HSPA1L (Affinity Capture-MS), STIP1 (Affinity Capture-MS), BAG3 (Affinity Capture-MS), HSPA2 (Affinity Capture-MS)
ESM2 similar proteins: A6NE02, A8MY62, C9JR72, D3Z7H8, D3ZU57, O09017, O15197, O19179, O95382, P0C0K6, P10588, P43136, P55203, Q02846, Q08DG4, Q15628, Q2KHV9, Q3U0S6, Q3UH93, Q5BK61, Q5U651, Q5W7P8, Q5ZMM1, Q6ZNJ1, Q6ZQA0, Q6ZVZ8, Q80ZD5, Q86WK7, Q8BH02, Q8BH83, Q8C828, Q8CIG9, Q8IUL8, Q8IYS2, Q8JGM4, Q8K2J9, Q8N239, Q8VHA6, Q91X21, Q96CD0
Diamond homologs: A0A0A6YY25, B2RXH4, E0CZ16, E1B932, E7F6F9, F1LZ52, F1LZF0, F1MBP6, O88282, O93567, O95198, P10074, P17789, P42282, P42283, P42284, Q01295, Q1H9T6, Q24174, Q24206, Q3B7M1, Q52KG4, Q53G59, Q53HC5, Q5R633, Q5REP9, Q5U374, Q66HD2, Q6NRH0, Q7KQZ4, Q7KRI2, Q867Z4, Q86B87, Q8BGY4, Q8BZM0, Q8CA72, Q8IN81, Q8JZP3, Q8K0L9, Q8N143
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
79 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 77 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2661882 | GRCh37/hg19 Xp22.12(chrX:21393016-21675906)x1 | Pathogenic |
SpliceAI
125 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| X:21657763:T:C | acceptor_gain | 0.9700 |
| X:21657763:T:TC | acceptor_gain | 0.9700 |
| X:21657767:A:T | acceptor_gain | 0.9700 |
| X:21657761:CTT:C | acceptor_gain | 0.7500 |
| X:21657762:TTT:T | acceptor_gain | 0.7500 |
| X:21658168:A:T | donor_gain | 0.7300 |
| X:21657763:T:G | acceptor_gain | 0.7100 |
| X:21658138:C:T | donor_gain | 0.7000 |
| X:21658137:A:T | donor_gain | 0.6900 |
| X:21658049:C:A | donor_gain | 0.6800 |
| X:21657766:C:CT | acceptor_gain | 0.6600 |
| X:21658048:T:TA | donor_gain | 0.6600 |
| X:21658165:TGCA:T | donor_gain | 0.6100 |
| X:21657761:C:CC | acceptor_gain | 0.5500 |
| X:21658172:CATCA:C | donor_loss | 0.5400 |
| X:21658173:ATCAC:A | donor_loss | 0.5400 |
| X:21658174:TCACC:T | donor_loss | 0.5400 |
| X:21658176:ACCTG:A | donor_loss | 0.5400 |
| X:21658177:CC:C | donor_loss | 0.5400 |
| X:21658178:C:G | donor_loss | 0.5400 |
| X:21658179:T:C | donor_loss | 0.5300 |
| X:21657789:T:TA | acceptor_gain | 0.5200 |
| X:21657760:G:C | acceptor_gain | 0.4900 |
| X:21658268:G:T | donor_gain | 0.4700 |
| X:21657762:T:C | acceptor_gain | 0.4600 |
| X:21658135:C:CA | donor_gain | 0.4600 |
| X:21658169:C:T | donor_gain | 0.4600 |
| X:21657766:C:G | acceptor_gain | 0.4500 |
| X:21658169:CACCA:C | donor_gain | 0.4500 |
| X:21657768:G:GC | acceptor_gain | 0.4400 |
AlphaMissense
4091 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:21656138:A:G | W551R | 0.996 |
| X:21656138:A:T | W551R | 0.996 |
| X:21657636:A:C | S51R | 0.995 |
| X:21657636:A:T | S51R | 0.995 |
| X:21657638:T:G | S51R | 0.995 |
| X:21655985:A:G | W602R | 0.994 |
| X:21655985:A:T | W602R | 0.994 |
| X:21656136:C:A | W551C | 0.994 |
| X:21656136:C:G | W551C | 0.994 |
| X:21655983:C:A | W602C | 0.993 |
| X:21655983:C:G | W602C | 0.993 |
| X:21656430:C:A | W453C | 0.993 |
| X:21656430:C:G | W453C | 0.993 |
| X:21656432:A:G | W453R | 0.993 |
| X:21656432:A:T | W453R | 0.993 |
| X:21656159:A:C | Y544D | 0.992 |
| X:21656006:A:C | Y595D | 0.991 |
| X:21656576:A:G | W405R | 0.990 |
| X:21656576:A:T | W405R | 0.990 |
| X:21657531:G:C | F86L | 0.989 |
| X:21657531:G:T | F86L | 0.989 |
| X:21657533:A:G | F86L | 0.989 |
| X:21657628:A:G | F54S | 0.989 |
| X:21657106:A:T | V228D | 0.986 |
| X:21657472:G:T | A106D | 0.986 |
| X:21657616:A:G | F58S | 0.986 |
| X:21656137:C:G | W551S | 0.985 |
| X:21656356:A:T | I478N | 0.985 |
| X:21656574:C:A | W405C | 0.985 |
| X:21656574:C:G | W405C | 0.985 |
dbSNP variants (sampled 300 via entrez): RS1001765910 (X:21660251 G>C,T), RS1002683955 (X:21659701 G>A), RS1003304266 (X:21657477 C>T), RS1003657552 (X:21658396 A>C), RS1004977735 (X:21660250 G>C), RS1005375887 (X:21659754 G>A), RS1005716312 (X:21658387 T>A), RS1006979758 (X:21656153 G>A), RS1007225236 (X:21658861 C>T), RS1007379122 (X:21655657 ACC>A,AC,ACCC), RS1008234104 (X:21659202 C>A,T), RS1008449809 (X:21656215 C>A,T), RS1008900228 (X:21655774 A>G), RS1009199657 (X:21658032 G>A,C), RS1009676653 (X:21659096 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases methylation | 2 |
| sodium arsenite | decreases methylation | 1 |
| Acetaminophen | increases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.